서저리 파트너스, Inc.
US ˙ NasdaqGS ˙ US86881A1007

SecuritySGRY / Surgery Partners, Inc.
InsiderDanielle Burkhalter
This page shows the track record and history of Burkhalter Danielle insider trades in Surgery Partners, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Danielle Burkhalter in SGRY / Surgery Partners, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SGRY / Surgery Partners, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Danielle Burkhalter in SGRY / Surgery Partners, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2026-03-13 3,469 12.8300 3,469 12.8300 44,507 14 11.4900 -4,648 -10.44
2026-03-06 7,736 13.6000 7,736 13.6000 105,210
2025-03-14 74 23.7800 74 23.7800 1,760
2025-03-10 1,240 24.1400 1,240 24.1400 29,934
2025-02-04 167 25.6800 167 25.6800 4,289
2024-06-12 6,000 26.3850 6,000 26.3850 158,310
2024-03-12 111 29.7400 111 29.7400 3,301
2024-03-11 127 29.5900 127 29.5900 3,758
2024-03-04 586 30.4100 586 30.4100 17,820
2024-02-14 192 33.4200 192 33.4200 6,417
2024-02-06 167 32.2400 167 32.2400 5,384
2023-03-15 4 30.2500 4 30.2500 121
2023-03-14 430 31.0900 430 31.0900 13,369
2023-03-13 136 30.0400 136 30.0400 4,085
2023-02-13 123 33.8800 123 33.8800 4,167
2023-01-31 757 33.5500 757 33.5500 25,397

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SGRY / Surgery Partners, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2026-03-16 2026-03-13 4 Burkhalter Danielle SGRY Common Stock S - Sale D 12.8300 -3,469 -45 76,864
2026-03-09 2026-03-06 4 Burkhalter Danielle SGRY Common Stock S - Sale D 13.6000 -7,736 -105 37,103
2026-03-09 2026-03-05 4 Burkhalter Danielle SGRY Common Stock A - Award D 14.1100 9,150 129 80,333
2026-03-09 2026-03-05 4 Burkhalter Danielle SGRY Common Stock A - Award D 14.1100 16,363 231 71,183
2026-03-09 2026-03-05 4 Burkhalter Danielle SGRY Common Stock A - Award D 14.1100 17,717 250 54,820
2025-03-17 2025-03-14 4 Burkhalter Danielle SGRY Common Stock S - Sale D 23.7800 -74 -2 44,839
2025-03-13 2025-03-10 4 Burkhalter Danielle SGRY Common Stock S - Sale D 24.1400 -1,240 -30 44,913
2025-03-06 2025-03-04 4 Burkhalter Danielle SGRY Common Stock A - Award D 23.8000 5,882 140 46,153
2025-03-06 2025-03-04 4 Burkhalter Danielle SGRY Common Stock A - Award D 23.8000 10,084 240 40,271
2025-02-04 2025-02-04 4 Burkhalter Danielle SGRY Common Stock S - Sale D 25.6800 -167 -4 30,187
2024-06-13 2024-06-12 4 Burkhalter Danielle SGRY Common Stock S - Sale D 26.3850 -6,000 -158 30,354
2024-03-13 2024-03-12 4 Burkhalter Danielle SGRY Common Stock S - Sale D 29.7400 -111 -3 36,354
2024-03-13 2024-03-11 4 Burkhalter Danielle SGRY Common Stock S - Sale D 29.5900 -127 -4 36,465
2024-03-06 2024-03-04 4 Burkhalter Danielle SGRY Common Stock S - Sale D 30.4100 -586 -18 36,592
2024-03-01 2024-02-28 4 Burkhalter Danielle SGRY Common Stock A - Award D 31.1800 6,414 200 37,178
2024-03-01 2024-02-28 4 Burkhalter Danielle SGRY Common Stock A - Award D 31.1800 320 10 30,764
2024-02-16 2024-02-14 4 Burkhalter Danielle SGRY Common Stock S - Sale D 33.4200 -192 -6 30,444
2024-02-08 2024-02-06 4 Burkhalter Danielle SGRY Common Stock S - Sale D 32.2400 -167 -5 30,636
2023-03-15 2023-03-15 4 Burkhalter Danielle SGRY Common Stock S - Sale D 30.2500 -4 -0 30,803
2023-03-15 2023-03-14 4 Burkhalter Danielle SGRY Common Stock S - Sale D 31.0900 -430 -13 30,807
2023-03-15 2023-03-13 4 Burkhalter Danielle SGRY Common Stock S - Sale D 30.0400 -136 -4 31,237
2023-03-06 3 Burkhalter Danielle SGRY Common Stock D 12,493
2023-03-06 2023-03-02 4 Burkhalter Danielle SGRY Common Stock A - Award D 32.8600 3,804 125 31,373
2023-03-06 2023-03-02 4 Burkhalter Danielle SGRY Common Stock A - Award D 32.8600 15,216 500 27,569
2023-03-06 2023-02-13 4 Burkhalter Danielle SGRY Common Stock S - Sale D 33.8800 -123 -4 13,110
2023-03-06 2023-01-31 4 Burkhalter Danielle SGRY Common Stock S - Sale D 33.5500 -757 -25 12,353
2023-03-06 2023-01-31 4 Burkhalter Danielle SGRY Common Stock A - Award D 54.0300 740 40 13,233
P
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입
S
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각
A
자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득
C
파생상품 전환
D
자사에게 유가증권을 매각 또는 양도
F
기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급
G
내부자에 의한 또는 내부자에게 증권 증여
K
지분스왑 및 유사 위험 회피거래
M
자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환
V
보고서 양식 4에 자진 신고된 거래
J
기타 (거래 내용을 설명하는 각주와 동반)